The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers

• Published in: Human gene therapy Vol. 11; no. 4; p. 521
• Main Authors: Pruchnic, R, Cao, B, Peterson, Z Q, Xiao, X, Li, J, Samulski, R J, Epperly, M, Huard, J
• Format: Journal Article
• Language: English
• Published: United States 01-03-2000
• Subjects: Animals; Dependovirus - genetics; Genes, Reporter; Genetic Therapy; Genetic Vectors; Heparan Sulfate Proteoglycans - metabolism; Immunohistochemistry; Lac Operon; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal - metabolism; Muscle, Skeletal - metabolism; Transduction, Genetic
• ISSN: 1043-0342
• DOI: 10.1089/10430340050015716

Muscle-based gene therapy using adenovirus, retrovirus, and herpes simplex virus has been hindered by viral cytotoxicity, host immune response, and the maturation-dependent viral transduction of muscle fibers. The development of new mutant vectors has greatly reduced the toxicity and the immune rejection problems, but the inability of viral vectors to penetrate and transduce mature myofibers remains an important issue. Research has been focused on the characterization of barriers to viral transduction in mature myofibers to develop strategies to circumvent the maturation-dependent viral transduction of myofibers. Here, we report that adeno-associated virus (AAV) can be used to overcome the maturation-dependent viral transduction of myofibers. We have investigated by which mechanism AAV can penetrate and efficiently transduce mature muscle fibers, and have shown that this viral vector is not blocked by the basal lamina and that AAV transduction of myofibers is independent of myoblast mediation. Although AAV can efficiently transduce mature myofibers, a differential transduction is still observed among the different types of myofibers that correlates with the expression of the heparan sulfate proteoglycan receptors, the muscle maturity, the number of viral particles used, and the time postinjection. The identification of the mechanisms by which AAV transduces mature myofibers will help in the development of strategies to achieve an efficient muscle-based gene therapy for inherited and acquired diseases.